InCerebro
About:
InCerebro is a pharmaceutical research and development company that offers drug development.
Website: http://incerebro.com
Top Investors: TIPS Program, HB Investment, Timepolio Asset Management, UTC Investment Co., Albatross Investment
Description:
Total Funding Amount:
5B KRW
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Seoul, Seoul-t'ukpyolsi, South Korea
Founded Date:
2019-01-01
Contact Email:
incerebro(AT)incerebro.com
Founders:
Art E. Cho
Number of Employees:
11-50
Last Funding Date:
2021-07-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai